| 000 | 01098 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513201722.0 | ||
| 264 | 0 | _c20000210 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a0277-0008 | ||
| 024 | 7 |
_a10.1592/phco.20.1.13.34667 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQaqish, R B | |
| 245 | 0 | 0 |
_aHIV-associated lipodystrophy syndrome. _h[electronic resource] |
| 260 |
_bPharmacotherapy _cJan 2000 |
||
| 300 |
_a13-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xchemically induced |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 | _aHIV-1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipodystrophy _xchemically induced |
| 650 | 0 | 4 |
_aLipoproteins _xdrug effects |
| 650 | 0 | 4 | _aSyndrome |
| 700 | 1 | _aFisher, E | |
| 700 | 1 | _aRublein, J | |
| 700 | 1 | _aWohl, D A | |
| 773 | 0 |
_tPharmacotherapy _gvol. 20 _gno. 1 _gp. 13-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1592/phco.20.1.13.34667 _zAvailable from publisher's website |
| 999 |
_c10597237 _d10597237 |
||